Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05RDO
|
|||
Former ID |
DNC012176
|
|||
Drug Name |
3-(6-Amino-purin-9-yl)-4-butoxy-butan-2-ol
|
|||
Synonyms |
CHEMBL606665; ZINC13835548
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C13H21N5O2
|
|||
Canonical SMILES |
CCCCOCC(C(C)O)N1C=NC2=C(N=CN=C21)N
|
|||
InChI |
1S/C13H21N5O2/c1-3-4-5-20-6-10(9(2)19)18-8-17-11-12(14)15-7-16-13(11)18/h7-10,19H,3-6H2,1-2H3,(H2,14,15,16)/t9-,10?/m0/s1
|
|||
InChIKey |
JLZPQJZPCMKWRD-RGURZIINSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Adenosine deaminase (ADA) | Target Info | Inhibitor | [1] |
BioCyc | Purine nucleotides degradation | |||
Purine deoxyribonucleosides degradation | ||||
Purine ribonucleosides degradation to ribose-1-phosphate | ||||
Adenosine nucleotides degradation | ||||
Superpathway of purine nucleotide salvage | ||||
Adenine and adenosine salvage III | ||||
KEGG Pathway | Purine metabolism | |||
Metabolic pathways | ||||
Primary immunodeficiency | ||||
NetPath Pathway | TCR Signaling Pathway | |||
IL2 Signaling Pathway | ||||
Panther Pathway | Adenine and hypoxanthine salvage pathway | |||
Pathwhiz Pathway | Purine Metabolism | |||
Pathway Interaction Database | p73 transcription factor network | |||
C-MYB transcription factor network | ||||
Validated transcriptional targets of deltaNp63 isoforms | ||||
Validated transcriptional targets of TAp63 isoforms | ||||
Reactome | Purine salvage | |||
WikiPathways | Metabolism of nucleotides |
References | Top | |||
---|---|---|---|---|
REF 1 | Adenosine deaminase inhibitors: synthesis and biological evaluation of unsaturated, aromatic, and oxo derivatives of (+)-erythro-9-(2'S-hydroxy-3'R... J Med Chem. 2000 Nov 30;43(24):4694-700. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.